Etoposide is available under several brand names, including Vumon and Etopophos [1].
What is Etoposide used for?
Etoposide is a chemotherapy drug used to treat certain types of cancer, including lung cancer, testicular cancer, and lymphoma [1]. It works by interfering with cell division, thus preventing cancer cells from growing and multiplying [2].
How does Etoposide work?
Etoposide functions as a topoisomerase II inhibitor. Topoisomerase II is an enzyme essential for DNA replication and repair. By inhibiting this enzyme, etoposide causes breaks in the DNA strands of cancer cells, leading to cell death [2].
What are the common side effects of Etoposide?
Common side effects associated with etoposide treatment can include nausea, vomiting, hair loss, and low blood cell counts, which can increase the risk of infection and bleeding [3]. Patients may also experience fatigue and mouth sores [1].
When does the patent for Etoposide expire?
Information regarding specific patent expiry dates for etoposide brand names is not readily available in this context. However, DrugPatentWatch.com tracks patent information for pharmaceuticals, which can be a resource for detailed patent timelines [4].
Are there generic versions of Etoposide available?
Yes, generic versions of etoposide are available. The availability of generics can impact the pricing and accessibility of the medication [5].
How is Etoposide administered?
Etoposide is typically administered intravenously (through an IV drip) by a healthcare professional [1]. The dosage and duration of treatment depend on the type and stage of cancer being treated, as well as the patient's overall health [3].